The $2.7M Commercialization Readiness Pilot grant, awarded as part of the Small Business Innovation Research Program, will be used to help commercialize OsteoBoost, an osteopenia treatment and osteoporosis prevention device.
Women Who Lead: Closing the medical research gap between men and women - San Francisco Business Times bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
Bone Health Technologies introduces the OsteoBoost Vibration Belt, designed to help treat osteopenia and prevent osteoarthritis. It has been granted “Breakthrough Device” designation by the US Food & Drug Administration.
OsteoBoost uses proprietary vibration technology designed to deliver gentle mechanical stimulation to the hips and spine at a precise, individually calibrated frequency, encouraging the body to reduce bone resorption and potentially create new bone. This localized vibration therapy’s effect is to stop the progression of bone loss and prevent the onset of osteoporosis.
An initial study suggests that one 30-minute treatment with OsteoBoost helps reduce bone loss activity in all study participants, providing an average decrease of 14%, a reduction on par with bisphosphonate drugs.